首页>
外国专利>
ACID-SENSITIVE GEFITINIB AXIALLY SUBSTITUTED SILICON PHTHALOCYANINE COMPLEX AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF
ACID-SENSITIVE GEFITINIB AXIALLY SUBSTITUTED SILICON PHTHALOCYANINE COMPLEX AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF
展开▼
机译:酸敏感的吉非替尼轴向取代的硅酞菁配合物及其制备方法和医学用途
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a slightly acidic environment-sensitive and ketal-linked gefitinib axially substituted silicon phthalocyanine complex and a preparation method therefor and a medical use thereof. In particular, the present invention relates to a silicon phthalocyanine-gefitinib complex as shown in general formula (I) and a preparation method therefor and a pharmaceutical composition containing the complex, and the use thereof as a photosensitiser, especially the use in the treatment of cancers, wherein the definition of each substituent in general formula (I) is the same as that in the description. In a normal tissue environment, due to the interplay of the silicon phthalocyanine group and the gefitinib group, the complex has a lower cytotoxicity. However, in the extracellular slightly-acidic environment of the tumour tissue, ketals hydrolyse and the fragments of the hydrolysate, i.e. silicon phthalocyanine, exhibit an extremely high photosensitive activity, while another hydrolysate, i.e. a gefitinib derivative, can be used as an inhibitor of epidermal growth factor receptor (EGFR) tyrosinase for inhibiting tumour growth. The complexes can be prepared into photodynamic therapeutic and chemotherapeutic double-efficacy anticancer drugs targeting both the tumour extracellular slightly-acidic environment and the EGFR tyrosine kinase.
展开▼